Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

UTHR

United Therapeutics Corp

Jun 18 • 04:00PM ET

306.04

Dollar change +8.98
Percentage change 3.02	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: IJH VTI VB VBR VXF COWZ MDY XBI IBB SPMD

Scroll to Statements

Index	-	P/E	14.47	EPS (ttm)	21.15	Insider Own	1.75%	Shs Outstand	47.04M	Perf Week	10.98%
Market Cap	13.58B	Forward P/E	11.21	EPS next Y	27.31	Insider Trans	-44.54%	Shs Float	43.59M	Perf Month	11.59%
Income	1.05B	PEG	1.49	EPS next Q	6.33	Inst Own	103.63%	Short Float	8.92%	Perf Quarter	27.84%
Sales	2.50B	P/S	5.44	EPS this Y	25.53%	Inst Trans	1.04%	Short Ratio	7.14	Perf Half Y	24.18%
Book/sh	120.76	P/B	2.53	EPS next Y	9.81%	ROA	16.36%	Short Interest	3.89M	Perf Year	32.91%
Cash/sh	61.03	P/C	5.01	EPS next 5Y	9.70%	ROE	20.08%	52W Range	208.62 - 297.70	Perf YTD	39.18%
Dividend Est.	-	P/FCF	17.98	EPS past 5Y	8.15%	ROI	18.97%	52W High	2.80%	Beta	0.54
Dividend TTM	-	Quick Ratio	3.64	Sales past 5Y	8.02%	Gross Margin	88.87%	52W Low	46.69%	ATR (14)	6.82
Dividend Ex-Date	-	Current Ratio	3.77	EPS Y/Y TTM	40.71%	Oper. Margin	50.31%	RSI (14)	83.38	Volatility	2.80% 2.32%
Employees	1168	Debt/Eq	0.11	Sales Y/Y TTM	26.09%	Profit Margin	42.05%	Recom	1.54	Target Price	300.91
Option/Short	Yes / Yes	LT Debt/Eq	0.04	EPS Q/Q	27.02%	Payout	0.00%	Rel Volume	1.57	Prev Close	297.06
Sales Surprise	9.25%	EPS Surprise	8.13%	Sales Q/Q	33.70%	Earnings	May 01 BMO	Avg Volume	544.32K	Price	306.04
SMA20	10.46%	SMA50	17.75%	SMA200	29.83%	Trades		Volume	852,690	Change	3.02%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-12-24	Upgrade	Goldman	Sell → Neutral	$213 → $215
Feb-05-24	Initiated	Leerink Partners	Outperform	$330
Dec-08-23	Initiated	Wells Fargo	Overweight	$309
Dec-06-22	Initiated	UBS	Buy	$320
Dec-05-22	Initiated	Goldman	Sell	$230
Oct-11-22	Initiated	Morgan Stanley	Overweight	$288
Sep-20-22	Reiterated	BofA Securities	Underperform
Sep-19-22	Resumed	Wedbush	Outperform	$263
Feb-11-22	Initiated	BTIG Research	Neutral
Jul-14-21	Upgrade	Argus	Hold → Buy	$205
Apr-26-21	Resumed	Credit Suisse	Outperform	$196
Feb-01-21	Upgrade	H.C. Wainwright	Neutral → Buy	$125 → $195
Sep-14-20	Resumed	JP Morgan	Overweight	$142
Jun-25-20	Reiterated	H.C. Wainwright	Neutral	$85 → $125
Mar-10-20	Upgrade	Jefferies	Hold → Buy	$123
Feb-27-20	Upgrade	Cowen	Market Perform → Outperform	$119 → $145
Jan-31-20	Upgrade	JP Morgan	Neutral → Overweight	$120
Dec-03-19	Initiated	BofA/Merrill	Underperform
Aug-01-19	Upgrade	Ladenburg Thalmann	Neutral → Buy	$103 → $106
Aug-01-19	Upgrade	Jefferies	Underperform → Hold	$90

Show Previous Ratings

Jun-18-24 07:00PM	Insider Sale: Director Judy Olian Sells Shares of United Therapeutics Corp (UTHR) (GuruFocus.com)
Jun-14-24 07:00PM	Insider Sale: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR) (GuruFocus.com)
Jun-07-24 09:40AM	Why United Therapeutics (UTHR) is a Top Value Stock for the Long-Term (Zacks)
Jun-05-24 07:00AM	United Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare Conference (Business Wire)
Jun-04-24 02:18PM	The 3 Most Undervalued Healthcare Stocks to Buy in June 2024 (InvestorPlace)
Jun-03-24 04:33PM	Liquidia Stock Surges After Winning Patent Battle Vs. United Therapeutics (Investor's Business Daily)
May-31-24 11:31AM	Why Is United Therapeutics (UTHR) Up 4.8% Since Last Earnings Report? (Zacks)
May-30-24 09:50AM	Here's Why United Therapeutics (UTHR) is a Strong Momentum Stock (Zacks)
May-27-24 10:11AM	3 Underappreciated Biotech Stocks to Buy Now: May 2024 (InvestorPlace)
May-23-24 09:45AM	Here's Why United Therapeutics (UTHR) is a Strong Growth Stock (Zacks)
May-22-24 09:40AM	Here's Why United Therapeutics (UTHR) is a Strong Value Stock (Zacks)
04:56AM	Latest 340B ruling delivers blow to providers (Healthcare Dive)
May-20-24 01:34PM	7 Biotech Stocks That Could Breathe New Life Into Your Portfolio (InvestorPlace)
May-16-24 07:01PM	Insider Sale: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR) (GuruFocus.com)
07:01PM	Insider Sale: CFO and Treasurer James Edgemond Sells 40,160 Shares of United Therapeutics Corp ... (GuruFocus.com)
May-15-24 02:05AM	Q1 2024 Liquidia Corp Earnings Call (Thomson Reuters StreetEvents)
May-14-24 04:39PM	United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing (MT Newswires)
May-10-24 04:41PM	United Therapeutics Insider Sold Shares Worth $1,898,393, According to a Recent SEC Filing (MT Newswires)
May-09-24 11:47AM	MannKind Corporation (NASDAQ:MNKD) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-08-24 05:15PM	United Therapeutics Insider Sold Shares Worth $949,737, According to a Recent SEC Filing (MT Newswires)
09:50AM	Why United Therapeutics (UTHR) is a Top Momentum Stock for the Long-Term (Zacks)
May-07-24 05:00PM	United Therapeutics Insider Sold Shares Worth $1,871,233, According to a Recent SEC Filing (MT Newswires)
02:23AM	Insider Sale: Director Judy Olian Sells Shares of United Therapeutics Corp (UTHR) (GuruFocus.com)
02:23AM	Insider Sale: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR) (GuruFocus.com)
May-06-24 04:43PM	United Therapeutics Insider Sold Shares Worth $2,585,601, According to a Recent SEC Filing (MT Newswires)
02:30PM	3 Biotech Stocks to Double Your Money in the Next 24 Months (InvestorPlace)
12:45PM	United Therapeutics (UTHR) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
09:45AM	Here's Why United Therapeutics (UTHR) is a Strong Growth Stock (Zacks)
09:15AM	United Therapeutics Corporation (UTHR) Hits Fresh High: Is There Still Room to Run? (Zacks)
May-05-24 08:19AM	Bright Horizons Family Solutions Inc. (NYSE:BFAM) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-03-24 07:50PM	Analyst Report: United Therapeutics Corporation (Morningstar Research)
04:39PM	United Therapeutics Insider Sold Shares Worth $1,829,903, According to a Recent SEC Filing (MT Newswires)
02:41PM	30 Most Profitable Companies with Highest Margins in the World (Insider Monkey)
May-02-24 11:59AM	United Therapeutics (UTHR) Q1 Earnings Top, Tyvaso Drives Sales (Zacks)
11:43AM	United Therapeutics Corporation (NASDAQ:UTHR) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:35AM	UBS Adjusts Price Target on United Therapeutics to $300 From $290, Maintains Buy Rating (MT Newswires)
09:54AM	Oppenheimer Adjusts United Therapeutics Price Target to $400 From $375, Maintains Outperform Rating (MT Newswires)
03:12AM	United Therapeutics Corp (UTHR) Q1 2024 Earnings Call Transcript Highlights: Record Revenue and ... (GuruFocus.com)
01:06AM	Decoding United Therapeutics Corp (UTHR): A Strategic SWOT Insight (GuruFocus.com)
12:07AM	Q1 2024 United Therapeutics Corp Earnings Call (Thomson Reuters StreetEvents)
May-01-24 04:35PM	Lung Disease-Focused United Therapeutics Says It Is A Compelling Investment Opportunity (Benzinga) +8.88%
09:30AM	Compared to Estimates, United Therapeutics (UTHR) Q1 Earnings: A Look at Key Metrics (Zacks)
08:46AM	United Therapeutics Q1 Net Income, Revenue Advance; Shares Rise Pre-Bell (MT Newswires)
07:51AM	United Therapeutics Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance (GuruFocus.com)
06:35AM	United Therapeutics: Q1 Earnings Snapshot (Associated Press Finance)
06:30AM	United Therapeutics Corporation Reports First Quarter 2024 Financial Results (Business Wire)
Apr-29-24 12:00PM	What Makes United Therapeutics (UTHR) a New Buy Stock (Zacks)
Apr-26-24 02:02PM	CORRECTING and REPLACING PHOTO United Therapeutics Announces Worlds First Successful Xenothymokidney Transplant (Business Wire)
Apr-24-24 12:10PM	Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report? (Zacks)
10:01AM	United Therapeutics (UTHR) Earnings Expected to Grow: Should You Buy? (Zacks)
09:00AM	United Therapeutics Announces Worlds First Successful Xenothymokidney Transplant (Business Wire)
07:00AM	United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024 (Business Wire)
Apr-23-24 04:39PM	United Therapeutics Insider Sold Shares Worth $1,704,174, According to a Recent SEC Filing (MT Newswires)
11:06AM	United Therapeutics Q1 Results Could Fall Short of Market Expectations, Oppenheimer Says (MT Newswires)
Apr-16-24 07:00AM	United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference (Business Wire)
Apr-10-24 01:46PM	Innovation in Healthcare: HTECs Q1 2024 Index Rebalance (ETF Trends)
Apr-06-24 01:55AM	Insider Sell: Chairperson & CEO Martine Rothblatt Sells 30,000 Shares of United ... (GuruFocus.com)
Apr-05-24 01:52AM	Insider Sell: EVP & GENERAL COUNSEL Paul Mahon Sells 6,000 Shares of United Therapeutics ... (GuruFocus.com)
Apr-03-24 08:02PM	3 Underappreciated Healthcare Stocks to Buy Now: April 2024 (InvestorPlace)
Mar-29-24 07:00PM	United Therapeutics Corp (UTHR) Chairperson & CEO Martine Rothblatt Sells 29,125 Shares (GuruFocus.com)
Mar-27-24 07:00PM	United Therapeutics Corp (UTHR) CEO Martine Rothblatt Sells 30,000 Shares (GuruFocus.com) -5.57%
Mar-26-24 10:00AM	United Therapeutics' Robust Portfolio Fuels Double-Digit Growth (GuruFocus.com)
07:00AM	United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation (Business Wire)
Mar-25-24 07:00PM	Insider Sell: United Therapeutics Corp (UTHR) Chairperson & CEO Martine Rothblatt Sells ... (GuruFocus.com)
07:00AM	United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program (Business Wire)
Mar-22-24 09:04PM	Insider Sell: EVP & GENERAL COUNSEL Paul Mahon Sells 6,000 Shares of United Therapeutics ... (GuruFocus.com)
11:30AM	Why Is United Therapeutics (UTHR) Up 8.9% Since Last Earnings Report? (Zacks)
Mar-21-24 07:01PM	United Therapeutics Corp (UTHR) Chairperson & CEO Martine Rothblatt Sells 30,000 Shares (GuruFocus.com)
Mar-17-24 08:50AM	30 Biggest Biotechnology Companies in the World (Insider Monkey)
Mar-16-24 02:42PM	Liquidia Corporation (NASDAQ:LQDA) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-13-24 10:54PM	Q4 2023 Liquidia Corp Earnings Call (Thomson Reuters StreetEvents)
03:12PM	The 3 Most Undervalued Nasdaq Stocks to Buy in March 2024 (InvestorPlace)
Mar-11-24 07:01PM	United Therapeutics Corp Chairperson & CEO Martine Rothblatt Sells 30,000 Shares (GuruFocus.com)
Mar-09-24 01:09PM	12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds (Insider Monkey)
Mar-08-24 03:01AM	Insider Sell: EVP & GENERAL COUNSEL Paul Mahon Sells 6,000 Shares of United Therapeutics ... (GuruFocus.com)
Mar-05-24 06:28AM	Game Changers: 3 Biotech Stocks That Could Be Multibaggers in the Making (InvestorPlace)
06:00AM	United Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024 (Business Wire)
Feb-27-24 06:00AM	United Therapeutics Corporation to Present at the TD Cowen 44th Annual Health Care Conference (Business Wire)
Feb-26-24 07:31PM	Analyst Report: United Therapeutics Corporation (Morningstar Research)
03:20PM	7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff (InvestorPlace)
Feb-23-24 05:40AM	5 Fastest Growing Biotech Companies in the US (Insider Monkey)
Feb-22-24 12:22PM	United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates (Zacks)
09:55AM	Wall Street Analysts Think United Therapeutics (UTHR) Could Surge 32.73%: Read This Before Placing a Bet (Zacks)
09:54AM	United Therapeutics Corporation (NASDAQ:UTHR) Q4 2023 Earnings Call Transcript (Insider Monkey)
09:45AM	Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term (Zacks)
01:16AM	Q4 2023 United Therapeutics Corp Earnings Call (Thomson Reuters StreetEvents)
12:03AM	Decoding United Therapeutics Corp (UTHR): A Strategic SWOT Insight (GuruFocus.com)
Feb-21-24 03:17PM	United Therapeutics' Challenges FDA Over Liquidia's Drug Approval Process, Clocks Strong Q4 Earnings (Benzinga)
09:30AM	United Therapeutics (UTHR) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
06:51AM	UPDATE 3-United Therapeutics starts litigation with FDA over rival Liquidia's drug application (Reuters)
06:31AM	United Therapeutics Corp Posts Record Annual Revenue, Net Income Soars in 2023 (GuruFocus.com)
06:24AM	United Therapeutics, in unusual step, sues FDA over rivals drug application (BioPharma Dive)
06:15AM	United Therapeutics: Q4 Earnings Snapshot (Associated Press Finance)
06:14AM	United Therapeutics Q4 Net Income Rises (RTT News)
06:04AM	United Therapeutics starts litigation with FDA for allowing Liquidia's drug application (Reuters)
06:00AM	United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
05:55AM	United Therapeutics Commences Litigation to Ensure Fairness in the Drug Review Process (Business Wire)
Feb-20-24 08:48AM	Why United Therapeutics (UTHR) Might Surprise This Earnings Season (Zacks)
Feb-19-24 09:15AM	Unveiling United Therapeutics (UTHR) Q4 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Feb-15-24 11:35PM	EVP & GENERAL COUNSEL Paul Mahon Sells 6,000 Shares of United Therapeutics Corp (UTHR) (GuruFocus.com)

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
PATUSKY CHRISTOPHER	Director	Jun 17 '24	Option Exercise	76.36	2,000	152,720	2,000	Jun 18 04:30 PM
PATUSKY CHRISTOPHER	Director	Jun 17 '24	Sale	295.50	2,000	591,000	0	Jun 18 04:30 PM
Olian Judy D.	Director	Jun 17 '24	Sale	295.43	1,700	502,225	5,605	Jun 18 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 14 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 17 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 14 '24	Sale	287.22	3,600	1,033,984	130	Jun 17 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 13 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 14 04:30 PM
CAUSEY CHRISTOPHER	Director	Jun 13 '24	Option Exercise	112.14	2,000	224,280	6,185	Jun 14 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 13 '24	Sale	285.48	3,600	1,027,716	130	Jun 14 04:30 PM
CAUSEY CHRISTOPHER	Director	Jun 13 '24	Sale	281.53	2,000	563,055	4,185	Jun 14 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 12 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 13 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 12 '24	Sale	281.19	3,600	1,012,293	130	Jun 13 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 11 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 13 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 11 '24	Sale	275.71	3,600	992,558	130	Jun 13 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 10 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 11 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 10 '24	Sale	273.95	3,600	986,204	130	Jun 11 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 07 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 11 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 07 '24	Sale	277.13	3,600	997,658	130	Jun 11 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 06 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 07 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 06 '24	Sale	276.98	3,600	997,124	130	Jun 07 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 05 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 07 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 05 '24	Sale	277.50	3,600	998,995	130	Jun 07 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 04 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 05 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 04 '24	Sale	273.38	3,600	984,150	130	Jun 05 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 03 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 05 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jun 03 '24	Sale	276.65	3,600	995,950	130	Jun 05 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	May 31 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 03 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	May 31 '24	Sale	272.48	3,600	980,940	130	Jun 03 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	May 30 '24	Option Exercise	129.49	3,600	466,164	3,730	Jun 03 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	May 30 '24	Sale	270.10	3,600	972,350	130	Jun 03 04:30 PM
ROTHBLATT MARTINE A	Director	May 29 '24	Option Exercise	129.49	3,600	466,164	3,730	May 30 04:30 PM
ROTHBLATT MARTINE A	Director	May 29 '24	Sale	267.13	3,600	961,663	130	May 30 04:30 PM
ROTHBLATT MARTINE A	Director	May 28 '24	Option Exercise	129.49	3,600	466,164	3,730	May 30 04:30 PM
ROTHBLATT MARTINE A	Director	May 28 '24	Sale	269.06	3,600	968,620	130	May 30 04:30 PM
ROTHBLATT MARTINE A	Director	May 24 '24	Option Exercise	129.49	3,600	466,164	3,730	May 28 04:30 PM
ROTHBLATT MARTINE A	Director	May 24 '24	Sale	272.53	3,600	981,119	130	May 28 04:30 PM
ROTHBLATT MARTINE A	Director	May 23 '24	Option Exercise	129.49	3,600	466,164	3,730	May 28 04:30 PM
ROTHBLATT MARTINE A	Director	May 23 '24	Sale	275.78	3,600	992,824	130	May 28 04:30 PM
ROTHBLATT MARTINE A	Director	May 21 '24	Option Exercise	129.49	3,600	466,164	3,730	May 22 04:30 PM
ROTHBLATT MARTINE A	Director	May 21 '24	Sale	275.85	1,468	404,947	130	May 22 04:30 PM
ROTHBLATT MARTINE A	Director	May 20 '24	Option Exercise	129.49	3,600	466,164	3,730	May 22 04:30 PM
ROTHBLATT MARTINE A	Director	May 20 '24	Sale	274.74	5,732	1,574,825	130	May 22 04:30 PM
ROTHBLATT MARTINE A	Director	May 17 '24	Option Exercise	129.49	3,600	466,164	3,730	May 20 04:30 PM
ROTHBLATT MARTINE A	Director	May 17 '24	Sale	273.27	3,600	983,765	130	May 20 04:30 PM
ROTHBLATT MARTINE A	Director	May 16 '24	Option Exercise	129.49	3,600	466,164	3,730	May 20 04:30 PM
ROTHBLATT MARTINE A	Director	May 16 '24	Sale	272.37	3,600	980,534	130	May 20 04:30 PM
EDGEMOND JAMES	CFO AND TREASURER	May 15 '24	Option Exercise	163.30	40,160	6,558,128	26,578	May 16 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	May 15 '24	Option Exercise	129.49	3,600	466,164	3,730	May 16 04:30 PM
CAUSEY CHRISTOPHER	Director	May 15 '24	Option Exercise	112.14	2,000	224,280	6,185	May 16 04:30 PM
EDGEMOND JAMES	CFO AND TREASURER	May 15 '24	Sale	272.69	40,160	10,951,230	1,578	May 16 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	May 15 '24	Sale	272.93	3,600	982,553	130	May 16 04:30 PM
CAUSEY CHRISTOPHER	Director	May 15 '24	Sale	272.90	2,000	545,800	4,185	May 16 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	May 14 '24	Option Exercise	129.49	3,600	466,164	3,730	May 16 04:30 PM
PATUSKY CHRISTOPHER	Director	May 14 '24	Option Exercise	76.26	1,310	99,901	1,310	May 15 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	May 14 '24	Sale	267.77	3,600	963,969	130	May 16 04:30 PM
PATUSKY CHRISTOPHER	Director	May 14 '24	Sale	264.35	1,310	346,299	0	May 15 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	May 13 '24	Option Exercise	129.49	3,600	466,164	3,730	May 14 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	May 13 '24	Sale	265.48	3,600	955,745	130	May 14 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	May 10 '24	Option Exercise	129.49	3,600	466,164	3,730	May 14 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	May 10 '24	Sale	265.50	3,600	955,788	130	May 14 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	May 09 '24	Option Exercise	129.49	3,600	466,164	3,730	May 10 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	May 09 '24	Sale	264.22	3,600	951,206	130	May 10 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	May 08 '24	Option Exercise	129.49	3,600	466,164	3,730	May 10 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	May 08 '24	Sale	263.11	3,600	947,186	130	May 10 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	May 07 '24	Option Exercise	129.49	3,600	466,164	3,730	May 08 04:31 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	May 07 '24	Sale	263.82	3,600	949,737	130	May 08 04:31 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	May 06 '24	Option Exercise	163.30	32,200	5,258,260	34,777	May 07 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	May 06 '24	Option Exercise	129.49	3,600	466,164	3,730	May 07 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	May 06 '24	Sale	259.70	3,600	934,929	130	May 07 04:30 PM
Olian Judy D.	Director	May 03 '24	Option Exercise	175.43	10,000	1,754,300	17,305	May 06 04:30 PM
SULLIVAN LOUIS W	Director	May 03 '24	Option Exercise	119.76	5,160	617,962	18,220	May 06 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	May 03 '24	Option Exercise	129.49	3,600	466,164	3,730	May 07 04:30 PM
CAUSEY CHRISTOPHER	Director	May 03 '24	Option Exercise	112.14	2,240	251,194	6,425	May 06 04:30 PM
Olian Judy D.	Director	May 03 '24	Sale	258.56	10,000	2,585,601	7,305	May 06 04:30 PM
SULLIVAN LOUIS W	Director	May 03 '24	Sale	258.39	5,160	1,333,285	13,060	May 06 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	May 03 '24	Sale	260.08	3,600	936,304	130	May 07 04:30 PM
CAUSEY CHRISTOPHER	Director	May 03 '24	Sale	259.91	2,240	582,195	4,185	May 06 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	May 02 '24	Option Exercise	129.49	3,600	466,164	3,730	May 03 04:31 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	May 02 '24	Sale	258.09	3,600	929,110	130	May 03 04:31 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	May 01 '24	Option Exercise	129.49	3,600	466,164	3,730	May 03 04:31 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	May 01 '24	Sale	250.22	3,600	900,793	130	May 03 04:31 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	Apr 30 '24	Option Exercise	129.49	3,600	466,164	3,730	May 01 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	Apr 30 '24	Sale	235.35	3,600	847,277	130	May 01 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	Apr 29 '24	Option Exercise	129.49	3,600	466,164	3,730	May 01 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	Apr 29 '24	Sale	238.64	3,600	859,088	130	May 01 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	Apr 26 '24	Option Exercise	129.49	3,600	466,164	3,730	Apr 29 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	Apr 26 '24	Sale	235.20	3,600	846,705	130	Apr 29 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	Apr 25 '24	Option Exercise	129.49	3,600	466,164	3,730	Apr 29 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	Apr 25 '24	Sale	235.53	3,600	847,920	130	Apr 29 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	Apr 24 '24	Option Exercise	129.49	3,600	466,164	3,730	Apr 25 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	Apr 24 '24	Sale	238.81	3,600	859,730	130	Apr 25 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	Apr 23 '24	Option Exercise	129.49	3,600	466,164	3,730	Apr 25 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	Apr 23 '24	Sale	236.38	3,600	850,983	130	Apr 25 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	Apr 22 '24	Option Exercise	129.49	3,600	466,164	3,730	Apr 23 04:30 PM
DWEK RAYMOND	Director	Apr 22 '24	Option Exercise	88.03	3,000	264,090	4,750	Apr 23 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	Apr 22 '24	Sale	236.47	3,600	851,298	130	Apr 23 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	Apr 19 '24	Option Exercise	129.49	3,600	466,164	3,730	Apr 23 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	Apr 19 '24	Sale	236.91	3,600	852,876	130	Apr 23 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	Apr 18 '24	Option Exercise	129.49	3,600	466,164	3,730	Apr 19 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	Apr 18 '24	Sale	237.91	3,600	856,462	130	Apr 19 04:30 PM
ROTHBLATT MARTINE A	CHAIRPERSON & CEO	Apr 17 '24	Option Exercise	129.49	3,600	466,164	3,730	Apr 19 04:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

UTHR

United Therapeutics Corp

Upgrade your FINVIZ experience